Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Glioma: Glioblastoma (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00586508
What this trial is testing

Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas

Who this might be right for
Recurrent Glioblastoma
Eli Lilly and Company 81
Testing effectiveness (Phase 2)Looking for participantsNCT04590664
What this trial is testing

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

Who this might be right for
GlioblastomaRecurrent Glioblastoma
Emory University 24
Early research (Phase 1)Study completedNCT00004892
What this trial is testing

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Very early researchStudy completedNCT02490930
What this trial is testing

A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Testing effectiveness (Phase 2)Study completedNCT02104882
What this trial is testing

INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study

Who this might be right for
Glioblastoma Multiforme
Universitätsmedizin Mannheim 12
Testing effectiveness (Phase 2)Study completedNCT02781792
What this trial is testing

Temozolomide Chronotherapy for High Grade Glioma

Who this might be right for
GliomaGlioblastoma Multiforme
Washington University School of Medicine 42
Not applicableUnknownNCT03997136
What this trial is testing

Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.

Who this might be right for
Supratentorial Glioblastoma
Assiut University 28
Testing effectiveness (Phase 2)Study completedNCT00085540
What this trial is testing

FR901228 in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT01257594
What this trial is testing

EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas

Who this might be right for
Brain Cancer
Andrew B Lassman, MD 22
Early research (Phase 1)Study completedNCT03020602
What this trial is testing

BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab

Who this might be right for
GliosarcomaRecurrent GlioblastomaAstrocytoma of Brain+1 more
Seema Nagpal 12
Testing effectiveness (Phase 2)Study completedNCT01478178
What this trial is testing

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

Who this might be right for
GliomaGlioblastomaGlioblastoma Multiforme+2 more
Kintara Therapeutics, Inc. 55
Testing effectiveness (Phase 2)Study completedNCT00672243
What this trial is testing

Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme

Who this might be right for
GlioblastomaGliosarcoma
Duke University 32
Testing effectiveness (Phase 2)Study completedNCT00165477
What this trial is testing

Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
GlioblastomaGliosarcomaMalignant Gliomas
Dana-Farber Cancer Institute 23
Early research (Phase 1)Active Not RecruitingNCT05835687
What this trial is testing

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Who this might be right for
Central Nervous System NeoplasmsAtypical Teratoid/Rhabdoid TumorDiffuse Midline Glioma, H3 K27M-Mutant+4 more
St. Jude Children's Research Hospital 29
Early research (Phase 1)Study completedNCT03072134
What this trial is testing

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

Who this might be right for
GliomaAnaplastic AstrocytomaAnaplastic Oligodendroglioma+5 more
Northwestern University 12
Not applicableStudy completedNCT04365647
What this trial is testing

Intra-operative Variation in Size of Brain Tumors After Craniotomy

Who this might be right for
Brain Tumor, Primary
Sheri Kashmir Institute of Medical Sciences 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT04145115
What this trial is testing

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

Who this might be right for
Astrocytoma, IDH-Mutant, Grade 4Diffuse GliomaGlioblastoma, IDH-Wildtype+1 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT01967810
What this trial is testing

ANG1005 in Patients With Recurrent High-Grade Glioma

Who this might be right for
GliomaGlioblastomaBrain Tumor, Recurrent
Angiochem Inc 73
Not applicableWithdrawnNCT03176160
What this trial is testing

LITT Palliative Treatment for Patients With Malignant Gliomas

Who this might be right for
Malignant Glioma of BrainGlioblastoma
Duke University
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Next Page